Metoprolol Tartrate And Hydrochlorothiazide Tablet
Product Images NDC 0378-0424

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metoprolol Tartrate And Hydrochlorothiazide (NDC 0378-0424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Label for Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP, 100 mg/50 mg, oral tablets. Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, made in India. The label indicates a 100-tablet bottle and features dosing, storage, and safety information, along with NDC 0378-0445-01 and a barcode.*
FDA Label Image

Image 02

Image 02
Label for Metoprolol Tartrate and Hydrochlorothiazide Tablets USP, 50 mg/25 mg, by Mylan Pharmaceuticals Inc. The label indicates 100 tablets per container, Rx only. It includes tablet imprint details (M 424), storage instructions, and dispensing guidelines with barcode and lot/expiration/serial number fields.*
FDA Label Image

Image 03

Image 03
Packaging label for Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, by Mylan Pharmaceuticals Inc. The label includes dosage form, strength, and quantity of 100 tablets. It features medication and storage instructions, a barcode, and product lot and expiration placeholders.*
FDA Label Image

Image 04

Image 04
Chemical structure diagram showing the molecular arrangement of metoprolol tartrate and hydrochlorothiazide, the active ingredients in the product Metoprolol Tartrate and Hydrochlorothiazide tablets by Mylan Pharmaceuticals Inc.*
FDA Label Image

Image 05

Image 05
Chemical structure diagram of the active ingredient hydrochlorothiazide, showing a chlorinated benzene ring with sulfonamide functional groups and an amino side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.